Patents Assigned to Alliance Discovery, Inc.
  • Compounds useful for inhibiting metastasis from cancer and methods using same
    Patent number: 10414771
    Abstract: The present invention includes compositions that are useful in preventing or treating metastasis in a subject diagnosed with cancer. The present invention also includes methods of preventing or treating metastasis in a subject diagnosed with cancer, wherein the method comprises administering to the subject in need thereof an effective amount of a pharmaceutical formulation comprising at least one pharmaceutically acceptable carrier and at least one CX3CR1 or fractalkine antagonist.
    Type: Grant
    Filed: November 22, 2017
    Date of Patent: September 17, 2019
    Assignees: Drexel University, Alliance Discovery, Inc.
    Inventors: Alessandro Fatatis, Joseph M. Salvino, Olimpia Meucci, Whitney L. Gladney
  • Compounds useful for inhibiting metastasis from cancer and methods using same
    Patent number: 9856260
    Abstract: The present invention includes compositions that are useful in preventing or treating metastasis in a subject diagnosed with cancer. The present invention also includes methods of preventing or treating metastasis in a subject diagnosed with cancer, wherein the method comprises administering to the subject in need thereof an effective amount of a pharmaceutical formulation comprising at least one pharmaceutically acceptable carrier and at least one CX3CR1 or fractalkine antagonist.
    Type: Grant
    Filed: June 6, 2016
    Date of Patent: January 2, 2018
    Assignees: Drexel University, Alliance Discovery, Inc.
    Inventors: Alessandro Fatatis, Joseph M. Salvino, Olimpia Meucci, Whitney L. Gladney
  • Compounds useful for inhibiting metastasis from cancer and methods using same
    Patent number: 9375474
    Abstract: The present invention includes compositions that are useful in preventing or treating metastasis in a subject diagnosed with cancer. The present invention also includes methods of preventing or treating metastasis in a subject diagnosed with cancer, wherein the method comprises administering to the subject in need thereof an effective amount of a pharmaceutical formulation comprising at least one pharmaceutically acceptable carrier and at least one CX3CR1 or fractalkine antagonist.
    Type: Grant
    Filed: February 25, 2013
    Date of Patent: June 28, 2016
    Assignees: Drexel University, Alliance Discovery, Inc.
    Inventors: Alessandro Fatatis, Joseph M. Salvino, Olimpia Meucci, Whitney L. Gladney
  • Compounds Useful for Inhibiting Metastasis from Cancer and Methods Using Same
    Publication number: 20130156761
    Abstract: The present invention includes compositions that are useful in preventing or treating metastasis in a subject diagnosed with cancer. The present invention also includes methods of preventing or treating metastasis in a subject diagnosed with cancer, wherein the method comprises administering to the subject in need thereof an effective amount of a pharmaceutical formulation comprising at least one pharmaceutically acceptable carrier and at least one CX3CR1 or fractalkine antagonist.
    Type: Application
    Filed: February 25, 2013
    Publication date: June 20, 2013
    Applicants: Alliance Discovery, Inc., Philadelphia Health & Education Corporation d/b/a Drexel University College of Medicine
    Inventors: Philadelphia Health & Education Corporation d/b/a Drexel University College of Medicine, Alliance Discovery, Inc.
  • Methods of inhibiting metastasis from cancer
    Patent number: 8435993
    Abstract: The present invention includes compositions that are useful in preventing or treating metastasis in a subject diagnosed with cancer. The present invention also includes methods of preventing or treating metastasis in a subject diagnosed with cancer, wherein the method comprises administering to the subject in need thereof an effective amount of a pharmaceutical formulation comprising at least one pharmaceutically acceptable carrier and at least one CX3CR1 or fractalkine antagonist.
    Type: Grant
    Filed: December 6, 2011
    Date of Patent: May 7, 2013
    Assignees: Philadelphia Health and Education Corporation, Alliance Discovery, Inc.
    Inventors: Alessandro Fatatis, Joseph M. Salvino, Olimpia Meucci, Whitney L. Jamieson